Zanubrutinib With Obinutuzumab in Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Clinical trial NCT06544785 · RECRUITING
Trial details
- NCT number
- NCT06544785
- Sponsor
- PETHEMA Foundation
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-02
- Primary completion
- 2032-05-31
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.